Thalassemia major
What is Thalassemia major?
Thalassemia major is a severe inherited blood disorder that affects how your body makes hemoglobin. Hemoglobin is the protein inside red blood cells that carries oxygen throughout your body. People with thalassemia major produce very little or no normal hemoglobin, which leads to severe anemia starting in early childhood.
This condition is also called Cooley's anemia or beta-thalassemia major. It occurs when you inherit two defective genes for hemoglobin production, one from each parent. Without treatment, the body cannot make enough healthy red blood cells to deliver oxygen to tissues and organs. This causes the bone marrow to work overtime trying to produce more cells, which can lead to bone changes and enlarged organs.
Thalassemia major is different from thalassemia minor or thalassemia trait. People with thalassemia minor carry one defective gene and usually have mild or no symptoms. Thalassemia major requires lifelong medical care including regular blood transfusions and iron management. Early diagnosis and consistent treatment help people with this condition live longer, healthier lives.
Symptoms
- Severe anemia causing extreme fatigue and weakness
- Pale or yellowish skin color
- Slowed growth and delayed puberty in children
- Facial bone deformities and enlarged head
- Swollen or enlarged abdomen from enlarged spleen and liver
- Dark-colored urine
- Shortness of breath and dizziness
- Heart problems including irregular heartbeat
- Frequent infections
- Bone weakness and fractures
Symptoms of thalassemia major typically appear during the first two years of life. Babies may seem healthy at birth but develop severe anemia as fetal hemoglobin is replaced by abnormal adult hemoglobin. Without early diagnosis and treatment, symptoms rapidly worsen and can become life-threatening.
Concerned about Thalassemia major? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Thalassemia major is caused by inheriting two mutated genes that control hemoglobin production. Each parent must pass down one defective gene for a child to develop the severe form. The mutations affect the beta-globin chains that make up hemoglobin, preventing normal red blood cell formation. This is a genetic condition present from birth, not something you can develop later in life or catch from others.
Risk factors include family history and ethnic background. Thalassemia major occurs most often in people of Mediterranean, Middle Eastern, South Asian, and African descent. If both parents carry the thalassemia trait, each pregnancy has a 25% chance of producing a child with thalassemia major. Genetic counseling before pregnancy can help families understand their risk and make informed decisions about testing and family planning.
How it's diagnosed
Thalassemia major is usually diagnosed in early childhood through blood tests that reveal severe anemia and abnormal red blood cells. A complete blood count shows a very low red blood cell count and small, pale red blood cells. Hemoglobin electrophoresis is a specialized test that identifies abnormal types of hemoglobin and confirms the diagnosis. Genetic testing can identify the specific mutations causing the condition.
Regular blood monitoring is essential for managing thalassemia major throughout life. Rite Aid offers Red Blood Cell Count testing as part of our flagship panel, which helps track anemia severity and response to treatment. Many people with thalassemia major need blood counts checked every few weeks to guide transfusion decisions. Newborn screening programs in many states now test for thalassemia, allowing for earlier diagnosis and treatment.
Treatment options
- Regular blood transfusions every 2 to 4 weeks to maintain healthy hemoglobin levels
- Iron chelation therapy to remove excess iron from repeated transfusions
- Folic acid supplements to support red blood cell production
- Bone marrow or stem cell transplant, which can cure thalassemia major in some cases
- Spleen removal surgery if the spleen becomes enlarged and destroys too many blood cells
- Regular monitoring of heart and liver function
- Adequate nutrition including calcium and vitamin D for bone health
- Vaccinations to prevent infections
- Avoiding iron supplements unless specifically prescribed
- Genetic counseling for family planning
Concerned about Thalassemia major? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Thalassemia major is the severe form that occurs when you inherit two defective genes, one from each parent. It causes severe anemia and requires lifelong treatment with regular blood transfusions. Thalassemia minor, also called thalassemia trait, occurs when you inherit only one defective gene. People with thalassemia minor usually have mild anemia or no symptoms and do not need transfusions.
Bone marrow transplant or stem cell transplant can cure thalassemia major. The procedure replaces defective blood-forming cells with healthy ones from a matched donor. However, transplants carry significant risks and require a compatible donor, usually a sibling. Most people with thalassemia major manage their condition with regular transfusions and chelation therapy rather than attempting a transplant.
Most people with thalassemia major need blood transfusions every 2 to 4 weeks. The frequency depends on how quickly their body breaks down red blood cells and their individual needs. Regular transfusions keep hemoglobin levels high enough to prevent symptoms and complications. Your doctor monitors your blood counts to determine the right transfusion schedule for you.
Iron chelation therapy uses medications to remove excess iron from your body. Regular blood transfusions cause iron to build up in organs like the heart and liver, which can cause serious damage over time. Chelation medications bind to iron and help your body eliminate it through urine or stool. This therapy is essential for preventing iron overload complications in people who receive frequent transfusions.
Yes, prenatal testing can diagnose thalassemia major during pregnancy. If both parents carry the thalassemia trait, genetic counseling and testing are recommended. Tests like chorionic villus sampling or amniocentesis can check fetal DNA for the mutations that cause thalassemia major. This information helps families prepare for a child's medical needs or make informed decisions about the pregnancy.
Without treatment, thalassemia major is life-threatening, usually within the first few years of life. Severe anemia prevents organs from getting enough oxygen to function properly. The bone marrow expands trying to make more blood cells, causing bone deformities and fractures. The spleen and liver become enlarged, and heart failure can develop. Regular transfusions and proper medical care are essential for survival.
People with thalassemia major need ongoing medical care including regular transfusions and daily chelation medications. These treatments require significant time and commitment but allow most people to attend school, work, and participate in normal activities. Fatigue may be an issue between transfusions. With proper treatment, many people with thalassemia major live into their 50s, 60s, or beyond and maintain good quality of life.
Yes, if one parent carries thalassemia trait, the other parent should definitely be tested before having children. A child can only develop thalassemia major if both parents pass down a defective gene. Simple blood tests can identify carriers. Genetic counseling helps families understand their specific risks and testing options during pregnancy if both partners are carriers.
People with thalassemia major should avoid iron-rich foods and iron supplements unless specifically prescribed, as transfusions already provide excess iron. A balanced diet with adequate calcium and vitamin D supports bone health. Folic acid from leafy greens and fortified foods helps red blood cell production. Your healthcare team can provide personalized nutrition guidance based on your chelation therapy and overall health status.
People with thalassemia major typically need blood tests every 2 to 4 weeks to check hemoglobin levels and determine transfusion timing. Additional testing monitors iron levels, liver function, and heart function every few months. Regular monitoring helps doctors adjust treatment and catch complications early. Consistent blood testing is a critical part of managing this condition and maintaining health long-term.